4/A
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001209191-22-030499
Chief Executive Officer sold 18,948 shares at $0.71 ($13,453)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2022-05-18 | Sale | −18,948 | $0.71 | $13,453 | 3,995,309 | D |
| Open-market sales · 18,948 sh · avg $0.71 · $13,453 | |||||||
Loading xslF345X03/doc4a.xml…